Results 151 to 160 of about 12,403,658 (278)

Online Access Information [PDF]

Clinical Gastroenterology and Hepatology, 2007
  +5 more sources

Explore barriers to using the internet for health information access in African countries: A systematic review. [PDF]

PLOS Digit Health
Chereka AA, Shibabaw AA, Butta FW, Tadesse MN, Abebe MT, Atanie FA, Kitil GW.   +6 more
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Exploring clinical trials awareness, information access and participation amongst Australians with ovarian cancer: a qualitative study. [PDF]

Support Care Cancer
Williams N, Russell H, Bradhurst B.
europepmc   +1 more source

Health Information and Information Access [PDF]

Information Development, 2003
openaire   +1 more source

Access to information in Bulgaria, 2008 [PDF]

, 2007
Kashumov, Alexander, Palova, Darina et al   +1 more
core  

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Information access and COVID-19 vaccination hesitancy among foreign-born persons in Sweden - a focus group interview-study. [PDF]

BMC Public Health
Söderberg M, Swaid J, Aurelius K, Rosengren A, Jakobsson K, Magnusson M.   +5 more
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

HPV Vaccination Information Access, Needs, and Preferences Among Black and Hispanic Mothers. [PDF]

J Health Commun
Kohler RE, Wagner RB, Vega J, Rivera YM, Kantor L, Greene K.   +5 more
europepmc   +1 more source